Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019

Publisher Name :
Date: 06-Feb-2019
No. of pages: 102
Inquire Before Buying

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.

The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Sanofi Pasteur

- GlaxoSmithKline

- Protein Sciences Corporation

- Novartis AG

- Seqirus

- Merck Sharp & Dohme Corp

- Astellas Pharma US, Inc

- Pfizer Inc

- Johnson & Johnson

- Lanzhou Institute of Biological Products Co., Ltd

- AstraZeneca

- Emergent BioSolutions Inc

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Immune DTaP Vaccine

- Therapy DTaP Vaccine

Segment by Application

- Adult

- Pediatric

Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019

Table of Contents
Executive Summary
1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Overview
1.1 Product Overview and Scope of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Immune DTaP Vaccine
1.2.3 Therapy DTaP Vaccine
1.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Application
1.3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Comparison by Application (2014-2025)
1.3.2 Adult
1.3.3 Pediatric
1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market by Region
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (2014-2025)
1.4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (2014-2025)
2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Competition by Manufacturers
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Manufacturers (2014-2019)
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites, Area Served, Product Types
2.5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Competitive Situation and Trends
2.5.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Rate
2.5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Regions
3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Regions
3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions (2014-2019)
3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
3.4.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
3.4.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
3.5.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
3.5.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (2014-2019)
3.6.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
3.6.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (2014-2019)
3.7.1 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
3.7.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Regions
4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Regions
4.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2014-2019)
4.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2014-2019)
4.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2014-2019)
4.5 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2014-2019)
5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price Trend by Type
5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Type (2014-2019)
5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2014-2019)
5.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type (2014-2019)
5.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth by Type (2014-2019)
6 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis by Applications
6.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Application (2014-2019)
6.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Business
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Protein Sciences Corporation
7.3.1 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Novartis AG
7.4.1 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Seqirus
7.5.1 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Merck Sharp & Dohme Corp
7.6.1 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.6.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Astellas Pharma US, Inc
7.7.1 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.7.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Pfizer Inc
7.8.1 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.8.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.9.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Lanzhou Institute of Biological Products Co., Ltd
7.10.1 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
7.10.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
7.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 AstraZeneca
7.12 Emergent BioSolutions Inc
8 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Cost Analysis
8.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
8.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
9.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Forecast
11.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue Forecast
11.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast (2019-2025)
11.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price and Trend Forecast (2019-2025)
11.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Forecast by Regions (2019-2025)
11.2.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue Forecast (2019-2025)
11.2.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue Forecast (2019-2025)
11.2.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue Forecast (2019-2025)
11.2.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue Forecast (2019-2025)
11.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Regions (2019-2025)
11.3.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2019-2025)
11.3.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2019-2025)
11.3.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2019-2025)
11.3.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2019-2025)
11.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Types in 2018
Figure Immune DTaP Vaccine Product Picture
Table Immune DTaP Vaccine Major Manufacturers
Figure Therapy DTaP Vaccine Product Picture
Table Therapy DTaP Vaccine Major Manufacturers
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Applications in 2018
Figure Adult
Figure Pediatric
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) (2014-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) of Key Manufacturers (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Manufacturers (2014-2019)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Manufacturers in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers in 2018
Table Global Market Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Average Price (USD/Dose) of Key Manufacturers (2014-2019)
Figure Global Market Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Average Price (USD/Dose) of Key Manufacturers in 2018
Table Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Types
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share of Top 5 Manufacturers
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share of Top 10 Manufacturers
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) by Region (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Region (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Region (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Region in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) by Region (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Region (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Region (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Region in 2018
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate (2014-2019)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate (2014-2019)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Market by Region (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Region (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Region (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Region in 2018
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) by Type (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Type (2014-2019)
Figure Production Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Type (2014-2019)
Figure Production Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Type in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) by Type (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Type (2014-2019)
Figure Revenue Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Type (2014-2019)
Figure Revenue Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Type in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose) by Type (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth by Type (2014-2019) (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) by Application (2014-2019)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Application (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Applications (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Application in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate by Application (2014-2019)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Growth Rate by Application (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Sanofi Pasteur Product Introduction, Application and Specification
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Sanofi Pasteur Main Business and Markets Served
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table GlaxoSmithKline Product Introduction, Application and Specification
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table GlaxoSmithKline Main Business and Markets Served
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Protein Sciences Corporation Product Introduction, Application and Specification
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Protein Sciences Corporation Main Business and Markets Served
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Novartis AG Product Introduction, Application and Specification
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Novartis AG Main Business and Markets Served
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Seqirus Product Introduction, Application and Specification
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Seqirus Main Business and Markets Served
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Merck Sharp & Dohme Corp Product Introduction, Application and Specification
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Merck Sharp & Dohme Corp Main Business and Markets Served
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Astellas Pharma US, Inc Product Introduction, Application and Specification
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Astellas Pharma US, Inc Main Business and Markets Served
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Pfizer Inc Product Introduction, Application and Specification
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Pfizer Inc Main Business and Markets Served
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Johnson & Johnson Product Introduction, Application and Specification
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Johnson & Johnson Main Business and Markets Served
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Lanzhou Institute of Biological Products Co., Ltd Product Introduction, Application and Specification
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Figure Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Figure Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industrial Chain Analysis
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price and Trend Forecast (2019-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Forecast by Region (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share Forecast by Region (2019-2025)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Forecast by Regions (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Forecast by Type (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Forecast by Type (2019-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share Forecast by Type (2019-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price (USD/Dose) Forecast by Type (2019-2025)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Forecast by Application (2019-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pemetrexed Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 123
    Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer. Scope of the Report: The worldwide market for Pemetrexed is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pem......
  • Global Drug Integrated Polymer Fibers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 103
    Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable polymers. These devices can be made from different materials and are available in custom sizes and shapes to meet specific biological requirements. With a rise in complexity along with technological innovations, textile devices are being designed to meet a broader range of applications than earlier which will boost the demand of drug integrated polymer fibers.......
  • Global Fast-dissolving Tablets Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 123
    Fast-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. Sc......
  • Global Fast-disintegrating Tablets Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 118
    Fast-disintegrating Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. ......
  • Global Rapid-dissolving Tablets Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 122
    Rapid-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. S......
  • Global Mouth-dissolving Tablets Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 122
    Mouth-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. S......
  • Global Orodispersible Tablets Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Aug-2019        Price: US 3480 Onwards        Pages: 117
    An Orodispersible Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. ......
  • Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights, Trends and Forecast (2019-2028)
    Published: 22-Aug-2019        Price: US 1600 Onwards        Pages: 96
    The global Non-Alcoholic Steatohepatitis (NASH) drugs market is expected to reach US$61.60 billion in 2028, growing at a CAGR of 39.36%, for the duration spanning 2018-2028. The factors such as rising prevalence of NASH, increasing diabetic population, rising obesity, unmet medical needs and sedentary lifestyle are expected to drive the growth of the market. However, the market growth would be challenged by lethargic drug approval process, high treatment cost and less definitive diagnostic me......
  • Global (United States, European Union and China) Endometriosis Market Research Report 2019-2025
    Published: 22-Aug-2019        Price: US 3280 Onwards        Pages: 121
    Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor. Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness am......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs